SECOND MESSENGER AND RECEPTOR SYSTEMS IN HUMAN SCLC
SECOND MESSENGER AND RECEPTOR SYSTEMS IN HUMAN SCLC
批准号:
3963280
负责人:
E SAUSVILLE
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
antibody specificity cell cell interaction cell growth regulation cell membrane cellular oncology crosslink drug design /synthesis /production gastrins guanosine diphosphate human tissue molecular oncology neoplasm /cancer therapy neoplastic cell oncoproteins peptide hormone pituitary gland small cell lung cancer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A) Gastrin Releasing Peptide Receptor: Model System. Gastrin-Releasing
Peptide is a 27 amino acid peptide derived from a proGRP precursor, of
which there are least three types which differ in relation to alternative
splicing at the 3' end of the precursor in a location not involving the GRP
portion of the molecule.
To focus on the nature of a receptor for GRP, GH3 cells, a cloned rat
pituitary cell line demonstrated enhanced phosphoinositide turnover in
response to binding of bombesin. This process was partially sensitive to
pertussis toxin and could be elicited by as low as 0.15 uM bombesin. On
examining SCLC cultures, preliminary experiments suggest a small but
reproducible tumor in phosphoinositide turnover after addition of bombesin
to a cell line known to have receptors.
Crosslinking agents have been used to confirm specific binding of labelled
GRP to GH3 and 3T3 cells, and will be used in further attempts to
characterize and perhaps purify the GRP receptor.
B. Guanine Nucleotide Regulatory Protein in Lung Cancer. Using type
specific antibodies, identification of Gs, Gi and Go was accomplished in
several small cell lung cancer cell lines. The physiologic relevance of
these proteins as regulators of human induced second message system will be
explored, via effects on cell growth, and interactions with other membrane
molecules by cross linking agents will be explored.
The significance of these studies is that definition of an autocrine role
for gastrin-releasing peptide by others in the lab needs to be pursued with
respect to how the growth activated pathway is mediated. Points where this
pathway feeds into intermediary metabolism could allow design of rational
therapeutic approaches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SECOND MESSENGER AND RECEPTOR SYSTEMS IN HUMAN SCLC
-
批准号:3916617
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
IMMUNOTOXIN PROTOCOLS
-
批准号:5201307
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
SECOND MESSENGER AND RECEPTOR SYSTEMS IN HUMAN SCLC
-
批准号:3939550
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
ENDOTHELIAL CELL TARGETED CANCER TREATMENT
-
批准号:3838151
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
TOXINS TARGETED TO THE CELL MEMBRANE--DISRUPTION OF SIGNAL TRANSDUCTION
-
批准号:3752418
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
PRECLINICAL AND CLINICAL PHARMACOLOGY OF PROTEIN KINASE ANTAGONISTS
-
批准号:3752419
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
G-PROTEIN EFFECTORS AS TARGETS FOR ANTINEOPLASTIC THERAPIES
-
批准号:3774670
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
PROTEIN KINASE ANTAGONISTS--PRECLINICAL AND CLINICAL STUDIES
-
批准号:2464490
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
ENDOTHELIAL CELL TARGETED CANCER TREATMENT
-
批准号:3774671
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
ENDOTHELIAL CELL TARGETED CANCER TREATMENT
-
批准号:3752421
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
PRECLINICAL PHARMACOLOGY OF PROTEIN KINASE ANTAGONISTS
-
批准号:3853203
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
G-PROTEIN EFFECTORS AS TARGETS FOR ANTINEOPLASTIC THERAPIES
-
批准号:3838150
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
TOXINS TARGETED TO THE CELL MEMBRANE--DISRUPTION OF SIGNAL TRANSDUCTION
-
批准号:5201344
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
PRECLINICAL AND CLINICAL PHARMACOLOGY OF PROTEIN KINASE ANTAGONISTS
-
批准号:5201345
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
G-PROTEIN EFFECTORS AS TARGETS FOR ANTINEOPLASTIC THERAPIES
-
批准号:3752420
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
TOXINS TARGETED TO THE CELL MEMBRANE--DISRUPTION IN SIGNAL TRANSDUCTION
-
批准号:3774668
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
TOXINS TARGETED TO THE CELL MEMBRANE--DISRUPTION IN SIGNAL TRANSDUCTION
-
批准号:3838148
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
IMMUNOTOXIN PROTOCOLS--TARGETED THERAPY OF LYMPHOID NEOPLASMS
-
批准号:6123682
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
LINEAGE-SPECIFIC MARKER AND PROTO-ONCOGENE EXPRESSION IN HUMAN LUNG CANCER
-
批准号:3939551
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
PRECLINICAL AND CLINICAL PHARMACOLOGY OF PROTEIN KINASE ANTAGONISTS
-
批准号:3774669
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
海外基金